These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36787734)

  • 1. SARS-CoV-2 Incubation Period during the Omicron BA.5-Dominant Period in Japan.
    Ogata T; Tanaka H
    Emerg Infect Dis; 2023 Mar; 29(3):595-598. PubMed ID: 36787734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response).
    Ogata T; Tanaka H
    Emerg Infect Dis; 2024 Jan; 30(1):207. PubMed ID: 38146992
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan.
    Cheng HY; Akhmetzhanov AR; Dushoff J
    Emerg Infect Dis; 2024 Jan; 30(1):206-207. PubMed ID: 38146985
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore.
    Zeng K; Santhya S; Soong A; Malhotra N; Pushparajah D; Thoon KC; Yeo B; Ho ZJM; Cheng MCI
    Emerg Infect Dis; 2023 Apr; 29(4):814-817. PubMed ID: 36878009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.
    Xu X; Wu Y; Kummer AG; Zhao Y; Hu Z; Wang Y; Liu H; Ajelli M; Yu H
    BMC Med; 2023 Sep; 21(1):374. PubMed ID: 37775772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain.
    Del Águila-Mejía J; Wallmann R; Calvo-Montes J; Rodríguez-Lozano J; Valle-Madrazo T; Aginagalde-Llorente A
    Emerg Infect Dis; 2022 Jun; 28(6):1224-1228. PubMed ID: 35393009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
    Xu R; Wang W; Zhang W
    Front Public Health; 2022; 10():1039123. PubMed ID: 36504951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant.
    Tanaka H; Ogata T; Shibata T; Nagai H; Takahashi Y; Kinoshita M; Matsubayashi K; Hattori S; Taniguchi C
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent and incubation periods of Delta, BA.1, and BA.2 variant cases and associated factors: a cross-sectional study in China.
    Li Y; Jiang X; Qiu Y; Gao F; Xin H; Li D; Qin Y; Li Z
    BMC Infect Dis; 2024 Mar; 24(1):294. PubMed ID: 38448822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of incubation periods of infections of Omicron variants BA.2 and BF.7 in Beijing].
    Xu X; Cai YX; Liu YH; Shen Y; Pan Y; Yao H; Wang XL; Yang P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Sep; 44(9):1397-1401. PubMed ID: 37743272
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.
    Ali KM; Rashid PMA; Ali AM; Tofiq AM; Salih GF; Dana OI; Rostam HM
    Eur J Clin Invest; 2023 Sep; 53(9):e14004. PubMed ID: 37036255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan.
    Ogata T; Tanaka H; Irie F; Hirayama A; Takahashi Y
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
    Bormann M; Brochhagen L; Alt M; Otte M; Thümmler L; van de Sand L; Kraiselburd I; Thomas A; Gosch J; Braß P; Ciesek S; Widera M; Dolff S; Dittmer U; Witzke O; Meyer F; Lindemann M; Schönfeld A; Rohn H; Krawczyk A
    Front Immunol; 2023; 14():1150667. PubMed ID: 37520539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice.
    Baz M; Deshpande N; Mackenzie-Kludas C; Mordant F; Anderson D; Subbarao K
    Emerg Infect Dis; 2022 Nov; 28(11):2352-2355. PubMed ID: 36191630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of SARS-CoV-2 Omicron BA.5 Infections, Macau, June-July 2022.
    Xiong W; Peng L; Tsang TK; Cowling BJ
    Emerg Infect Dis; 2023 Feb; 29(2):453-456. PubMed ID: 36648122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
    Pedersen RM; Bang LL; Madsen LW; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE
    Emerg Infect Dis; 2022 Jun; 28(6):1274-1275. PubMed ID: 35356875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections.
    Pedersen RM; Bang LL; Tornby DS; Madsen LW; Holm DK; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE
    Emerg Infect Dis; 2022 Dec; 28(12):2575-2577. PubMed ID: 36347270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants.
    Guo Z; Zhao S; Mok CKP; So RTY; Yam CHK; Chow TY; Chan TCP; Wei Y; Jia KM; Wang MH; Chong KC; Yeoh EK
    J Med Virol; 2023 Mar; 95(3):e28648. PubMed ID: 36892159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.